US Patent Issued to SUNGKWANG MEDICAL FOUNDATION on April 15 for "PCNT as a target protein for treatment or diagnosis of brain-nervous system diseases" (South Korean Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,717, issued on April 15, was assigned to SUNGKWANG MEDICAL FOUNDATION (Seoul, South Korea).

"PCNT as a target protein for treatment or diagnosis of brain-nervous system diseases" was invented by Minyoung Kim (Seoul, South Korea) and Jee In Choi (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a pharmaceutical composition for preventing or treating a central nervous system disease including, as an active ingredient, cord blood or cord blood-derived cells expressing or secreting pericentrin (PCNT), a composition or kit for diagnosing a central nervous system disease including an agent for measuring a level of PCNT p...